$18.9B
$489,000
0.01% of portfolio
17,384
Q4 2024
Reduced 8.93%
$37.1B
$665,000
0.01% of portfolio
11,835
Q4 2024
Added 3.99%
$653M
$475,000
0.01% of portfolio
33,529
Q1 2024
Added 16.81%
$6.72B
$503,000
0.01% of portfolio
1,773
Q4 2024
Reduced 5.34%
$0
$364,000
0.01% of portfolio
4,502
Q4 2024
Reduced 6.01%
$10.9B
$809,000
0.01% of portfolio
4,867
Q4 2024
Reduced 19.78%
$38.1B
$509,000
0.01% of portfolio
7,540
Q4 2024
Reduced 3.2%
$2.5B
$594,000
0.01% of portfolio
15,362
Q4 2024
New
$19.6B
$484,000
0.01% of portfolio
10,060
Q4 2024
Reduced 1.74%
$12.6B
$746,000
0.01% of portfolio
1,932
Q4 2024
Reduced 2.28%
$21.4B
$646,000
0.01% of portfolio
6,116
Q4 2024
Added 3.42%
$585M
$488,000
0.01% of portfolio
24,180
Q4 2024
Reduced 3.48%
$1.65B
$466,000
0.01% of portfolio
14,047
Q4 2024
New
$7.08B
$637,000
0.01% of portfolio
5,177
Q4 2024
Reduced 6.94%
$9.09B
$363,000
0.01% of portfolio
5,332
Q4 2024
Reduced 6.95%
$17B
$543,000
0.01% of portfolio
6,298
Q4 2024
Reduced 10.81%
$14.8B
$539,000
0.01% of portfolio
5,361
Q4 2024
Added 0.85%
$12.8B
$408,000
0.01% of portfolio
14,104
Q4 2024
New
$81.4B
$679,000
0.01% of portfolio
1,841
Q4 2024
Added 5.74%
$32.7B
$518,000
0.01% of portfolio
1,663
Q4 2024
Reduced 20.32%
$46.7B
$785,000
0.01% of portfolio
9,259
Q4 2024
Reduced 8.77%
$38.5B
$655,000
0.01% of portfolio
3,180
Q4 2024
Added 2.42%
$4.96B
$593,000
0.01% of portfolio
2,769
Q4 2024
Added 9.06%
$14.1B
$847,000
0.01% of portfolio
2,545
Q4 2024
Added 6.04%
$25.6B
$994,000
0.01% of portfolio
10,394
Q3 2024
Added 0.02%
$83.7B
$526,000
0.01% of portfolio
1,239
Q4 2024
Added 0.49%
$55.2B
$439,000
0.01% of portfolio
1,907
Q4 2024
Reduced 36.94%
$15.9B
$472,000
0.01% of portfolio
12,302
Q4 2024
Reduced 12.79%
$0
$323,000
0.0% of portfolio
3,000
Q4 2024
Reduced 30.52%
-
$0
0.0% of portfolio
-
Q3 2023
New
$2.01B
$223,000
0.0% of portfolio
5,627
Q4 2024
Added 25.24%
$1.62B
$225,000
0.0% of portfolio
1,800
Q2 2024
New
$13.6B
$244,000
0.0% of portfolio
2,285
Q4 2024
Reduced 0.78%
$0
$102,000
0.0% of portfolio
26,800
Q4 2024
Added 8.06%
$54.2B
$284,000
0.0% of portfolio
3,633
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Added 0.22%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 4.05%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 3.95%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 4.52%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 3.13%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 7.03%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 48.28%
$6.86B
$234,000
0.0% of portfolio
2,726
Q4 2024
Reduced 22.91%
$12.6B
$260,000
0.0% of portfolio
2,667
Q4 2024
Reduced 13.13%
$3.63B
$66,000
0.0% of portfolio
15,005
Q4 2024
Reduced 11.78%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 48.84%
-
$0
0.0% of portfolio
-
Q4 2024
Added 197.45%